Adverse events following immunization (AEFIs) with anti-meningococcus type B vaccine (4CMenB): Data of post-marketing active surveillance program. Apulia Region (Italy), 2019–2023
2023 · Vaccine · 6 citations
https://doi.org/10.1016/j.vaccine.2023.09.061